期刊文献+

零下非结冰UW液成功保存生物人工肝用L-02肝细胞 被引量:1

Storage of L-02 hepatocytes for bioartificial liver in UW solution at non-freezing points below zero
下载PDF
导出
摘要 目的比较零下非结冰(-0.8℃)与常规低温(4℃)分别用于人工肝用永生化L-02细胞保存的效果,探索零下非结冰保存肝细胞与细胞凋亡的关系。方法制备好的UW液保存的L-02细胞悬液分为以下2组:-0.8℃组(零下非结冰组),4℃组(对照组)。低温保存24、48h及72h后,分别测定细胞存活率、凋亡率、坏死率(流式细胞术)及ALT释放、尿素合成功能、白蛋白分泌功能。结果 -0.8℃(零下非结冰)较4℃明显提高了长时间低温保存L-02细胞的存活率[72h:(70.17±2.82)%vs(60.05±3.17)%,P<0.01],降低了细胞凋亡率[72h:(5.73±1.68)%vs(9.20±2.35)%,P=0.02],抑制了ALT释放[72h:(6.21±0.65)U/Lvs(8.68±1.18)U/L,P<0.01],更好地维持了L-02细胞的尿素合成功能[72h:(1.01±0.14)mmol/Lvs(0.66±0.09)mmol/L,P<0.01]及白蛋白分泌功能[72h:(9.04±0.53)μg/mlvs(7.70±0.52)μg/ml,P<0.01]。2组间细胞坏死率差异无统计学意义[72h:(18.45±1.88)%vs(21.82±3.86)%,P>0.05]。结论零下非结冰可明显维持L-02细胞存活率,降低低温损伤引起的细胞凋亡,有效保护肝细胞尿素合成和白蛋白分泌功能。 Objective To investigate the effect of subzero nonfreezing storage temperature ( - 0.8℃ ) compared with that of conventional hypothermic storage temperature (4 % ) for L-02 hepatocytes in UW solution in bioartificial liver support system (BLASS) and the relationship of this storage with cells apoptosis. Methods L-02 hepatocytes suspended in UW solution were divided into the following 2 groups, subzero nonfreezing group ( -0.8℃ ) and control group (4 % ). After 24, 48 and 72 h of hypothermic storage, the cell viability and cell apoptosis were measured with flow cytometry. Alanine transferase (ALT) release, the ability of hepatocytes to synthesize urea and secrete albumin were also studied. Results Significant improvement of cell viability was observed in subzero nonfreezing group compared with that in the control group [ 72 h: (70. 17 ±2. 82) % vs (60.05 ± 3. 17 ) %, P 〈 0. 011. Cell apoptosis was inhibited in subzero nonfreezing group [ 72 h : (5.73 ±1.68)% vs (9.20±2.35)%, P=0.02], and so did ALT secretion [72 h: (6.21 ±0.65) U/L vs (8.68±1.18) U/L, P 〈0. 01 ]. The ability of hepatocytes to synthesize urea [ 72 h: (1.01± 0. 14) mmol/L vs (0.66±0.09) mmo[/L, P 〈0. 01) and to secrete albumin [72 h: (9.04±0.53) μg/ml vs (7.70 ± 0. 52) p,g/ml, P 〈 0.01 ] were also better maintained in subzero nonfreezing group. There was no difference between the 2 groups in the cellular necrosis rate [72 h: ( 18.45 ± 1.88)% vs (21.82 ± 3.86)%, P 〉 0. 05 ]. Conclusion Subzero nonfreezing storage ( - 0.8 ℃ ) of L-02 hepatocytes in UW solution provides better cell viability and abilities of hepatocytes to synthesize urea and secrete albumin, and lower cell apoptosis. Subzero nonfreezing storage ( - 0.8 ℃ ) of hepatocytes and constructing a "ready to use" hepatocytes bank will efficiently promote the development of the BLASS.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2010年第16期1720-1723,共4页 Journal of Third Military Medical University
基金 全军医学科研"十一五"计划专项课题(08Z0170) 国家高技术研究发展计划(863计划 2006AA02A141)~~
关键词 生物人工肝 零下非结冰 细胞凋亡 bioartificial liver support system subzero nonfreezing cell apoptosis
  • 相关文献

参考文献3

二级参考文献41

  • 1Lu, Sen,Yu, Yue,Gao, Yun,Li, Guo-Qiang,Wang, Xue-Hao.Immunological inhibition of transplanted liver allografts by adeno-associated virus vector encoding CTLA4Ig in rats[J].Hepatobiliary & Pancreatic Diseases International,2008,7(3):258-263. 被引量:10
  • 2Guo-Ping Jiang, Zhen-Hua Hu, Shu-Sen Zheng, Chang-Ku Jia, Ai-Bin Zhang, Wei-Lin Wang, Department of Hepatobiliary Pancreatic Surgery, Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, The First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou 310003, Zhejiang Province, China.Adenovirus-mediated CTLA4Ig gene inhibits infiltration of immune cells and cell apoptosis in rats after liver transplantation[J].World Journal of Gastroenterology,2005,11(7):1065-1069. 被引量:14
  • 3Demetriou AA,Brown RS Jr,Busuttil RW,Fair J,McGuire BM,Rosenthal P,Am Esch JS 2nd,Lerut J,Nyberg SL,Salizzoni M,Fagan EA,de Hemptinne B,Broelsch CE,Muraca M,Salmeron JM,Rabkin JM,Metselaar HJ,Pratt D,De La Mata M,McChesney LP,Everson GT,Lavin PT,Stevens AC,Pitkin Z,Solomon BA.Prospective,randomized,multicenter,controlled trial of a bioartificial liver in treating acute liver failure.Ann Surg 2004; 239:660-667; discussion 667-670.
  • 4Gerlach JC,Mutig K,Sauer IM,Schrade P,Efimova E,Mieder T,Naumann G,Grunwald A,Pless G,Mas A,Bachmann S,Neuhaus P,Zeilinger K.Use of primary human liver cells originating from discarded grafts in a bioreactor for liver support therapy and the prospects of culturing adult liver stem cells in bioreactors:a morphologic study.Transplantation 2003; 76:781-786.
  • 5Fiegel HC,Kaufmann PM,Bruns H,Kluth D,Horch RE,Vacanti JP,Kneser U.Hepatic tissue engineering:from transplantation to customized cell-based liver directed therapies from the laboratory.J Cell Mol Med 2008; 12:56-66.
  • 6Lloyd TD,Orr S,Berry DP,Dennison AR.Development of a protocol for cryopreservation of hepatocytes for use in bioartificial liver systems.Ann Clin Lab Sci 2004; 34:165-174.
  • 7Llarrull MS,Pizarro MD,Scandizzi AL,Bottai H,Guibert EE,Rodriguez JV.Cold preservation of isolated hepatocytes in UW solution:experimental studies on the respiratory activity at 0 degrees C.Cryo Letters 2007; 28:313-328.
  • 8Fleming KK,Hubel A.Cryopreservation of hematopoietic and non-hematopoietic stem cells.Transfus Apher Sci 2006; 34:309-315.
  • 9Matsumoto N,Yoshizawa H,Kagamu H,Abe T,Fujita N,Watanabe S,Kuriyama H,Ishiguro T,Tanaka J,Suzuki E,Kobayashi K,Gemma A,Kudoh S,Gejyo F.Successful liquid storage of peripheral blood stem ceils at subzero non-freezing temperature.Bone Marrow Transplant 2002; 30:777-784.
  • 10Soltys KA,Batta AK,Koneru B.Successful nonfreezing,subzero preservation of rat liver with 2,3-butanediol and type Ⅰ antifreeze protein.J Surg Res 2001; 96:30-34.

共引文献20

同被引文献25

  • 1Belzer FO, Southard JH. Principles of solid-organ preservation by cold storage[ J ]. Transplantation, 1988,45 (4) :673-676.
  • 2Feng L, Zhao N, Yao X, et al. Histidine-tryptophan-ketoglutarate solution vs. University of Wisconsin solution for liver transplantation: a systematic review [J]. Liver Transpl, 2007,13 ( 8 ) : 1125- 1136.
  • 3Meine MH, Zanotclli ML, Neumann J, et al. Randomized clinical assay for hepatic grafts preservation with University of Wisconsin or histidine-tryptophan-ketoglutarate solutions in liver transplantation [ J ]. Transplant Proc, 2006,38 ( 6 ) : 1872-1875.
  • 4Erhard J, Lange R, Seherer R, et al. Comparison of histidinetrvplophan-ketoglutarate (HTK) solution versus University of Wiseunsln (UW) solution for organ preservation in human liver transplantation. A prospective, randomized study [ J ]. Transpl Int, 1994,7(3) :177-181.
  • 5Canelo R, Hakim NS, Ringe B. Experience with hystidine tryptophan ketoglutarate versus University Wisconsin preservation solu- Lions in transplantation[J].Int Surg, 2003,88 ( 3 ) : 145-151.
  • 6Testa G, Malag M, Nadalin S, et al. Histidine-tryptophan-ketogiutarate versus University of Wisconsin solution in living donor liver transplantation : resuhs of a prospective study [ J ]. Liver Transpl, 2003,9( 8 ) :822-826.
  • 7Avolio AW, Agnes S, Nure E, et al. Comparative evaluation of two perfusion solutions for liver preservation and transplantation [ J ]. Transplant Proc, 2006,38 ( 4 ) : 1066-1067.
  • 8Mangus RS, Teetor AJ, Agarwal A, et al. Comparison of histi- dine-tryptophan-ketoglutarate solution (HTK) and University of Wisconsin snlution (UW) in adult liver transplantation[ J]. Liver Transp1,2006,12 (2) :226-230.
  • 9Moray G, Sevmis S, Karakayali FY, et al. Comparison of histidine-tryptnphan-ketnglutarate and University of Wisconsin in living-donor liver transplantation [ J ]. Transplant Proc, 2006, 38 (10) :3572-3575.
  • 10Jain A, Mohanka R, Orloff M, et al. University of Wisconsin versus hlstidine-tryptophan-ketoglutarate for tissue preservation in live-donor liver transplantation [J]. Exp Clin Transplant,2006,4 (1 ) :451-457.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部